Overview

Alfentanil: Simultaneous Testing Pilot

Status:
Completed
Trial end date:
2016-09-01
Target enrollment:
Participant gender:
Summary
To evaluate two paradigms for simultaneous assessment of hepatic and intestinal CYP3A activity.
Phase:
N/A
Details
Lead Sponsor:
Washington University School of Medicine
Collaborator:
National Institute of General Medical Sciences (NIGMS)
Treatments:
Alfentanil
Ketoconazole
Rifampin